Daoran Lu
Qingdao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The dual role of TRPA1 in dextran sulfate sodium (DSS)-induced murine colitis: Suppression alleviates acute inflammation but exacerbates subacute disease.
Journal: Bioscience trends
Published: January 25, 2026
Development of Hydrophobic Tag Based HDAC6 Degrader for Ulcerative Colitis Treatment.
Journal: Journal of medicinal chemistry
Published: January 23, 2026
Paltusotine: The first selective nonpeptide agonist of somatostatin receptor 2 (SSTR2) for the treatment of acromegaly.
Journal: Drug discoveries & therapeutics
Published: October 29, 2025
Telisotuzumab vedotin: The first-in-class c-Met-targeted antibody-drug conjugate granted FDA accelerated approval for treatment of non-squamous non-small cell lung cancer (NSCLC).
Journal: Drug discoveries & therapeutics
Published: July 13, 2025
Trpa1 knockout favors colon tumorigenesis in dextran sulfate sodium (DSS)-induced colitis mice.
Journal: Drug discoveries & therapeutics
Published: June 22, 2025
Fitusiran: The first approved siRNA therapy for hemophilia via reducing plasma antithrombin levels.
Journal: Drug discoveries & therapeutics
Published: April 13, 2025
Vimseltinib: A novel colony stimulating factor 1 receptor (CSF1R) inhibitor approved for treatment of tenosynovial giant cell tumors (TGCTs).
Journal: Intractable & rare diseases research
Published: February 19, 2025
Tailored to fit: China optimizes policies and regulations regarding drug registration and review to promote innovation in traditional Chinese medicine.
Journal: Drug discoveries & therapeutics
Published: July 21, 2024
Development of amyloid beta-directed antibodies against Alzheimer's disease: Twists and turns.
Journal: Drug discoveries & therapeutics
Published: January 14, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026